A phase I study of continuous veliparib in combination with IV carboplatin/paclitaxel or IV/IP paclitaxel/cisplatin and bevacizumab in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube, or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study Meeting Abstract

  

Authors:	Bell-Mcguinn, K. M.; Brady, W. E.; Schilder, R. J.; Fracasso, P. M.; Moore, K. N.; Walker, J. L.; Duska, L. R.; Mathews, C. A.; Chen, A.; Shepherd, S. P.; Giranda, V. L.; Aghajanian, C.
Abstract Title:	A phase I study of continuous veliparib in combination with IV carboplatin/paclitaxel or IV/IP paclitaxel/cisplatin and bevacizumab in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube, or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study
Meeting Title:	51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	15 Suppl.
Meeting Dates:	2015 May 29-Jun 2
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-05-20
Language:	English
ACCESSION:	WOS:000358036901165
PROVIDER:	wos
DOI:	10.1200/jco.2015.33.15_suppl.5507
Notes:	Meeting Abstract: 5507 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/80368